diff --git a/pages/STOP2030___Web___Update 2024___02.md b/pages/STOP2030___Web___Update 2024___02.md
index e223a864..4a5a2b35 100644
--- a/pages/STOP2030___Web___Update 2024___02.md	
+++ b/pages/STOP2030___Web___Update 2024___02.md	
@@ -97,7 +97,10 @@
 				- Un safety and effectiveness study
 					- Primary objective: evaluate and compare safety of the [[FDC]] against [[albendazole]] alone via [[MDA]] in two study areas in [[Kenya]] and [[Ghana]]
 					- Secondary objectives:
-						- Evaluate the effectiveness of one round of MDA with FDC vs albendazole against STH by microscopy
+						- Evaluate the effectiveness of one round of [[MDA]] with [[FDC]] vs [[albendazole]] against [[STH]] by microscopy
+						- Evaluate the effectiveness of one round of [[MDA]] with [[FDC]] vs [[albendazole]] against [[Strongyloides stercolaris]] by serology
+					- Primary goal: Safety (incidence of SAEs)
+					- Secondary goals: Effectiveness at
 			- Nuestros objetivos:
 				- Overall goal: Support the achievement of the [[WHO]] 2030 NTD Roadmap for [[STH]] and beyond
 				- Project purpose: Advance and accelerate an innovative pharmacological tool to support the elimination goals against [[STH]] species, especially those poorly responsive to current treatment regimens
\ No newline at end of file